Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic
  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Gevo Reports Third Quarter 2024 Financial Results

ENGLEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the third quarter 2024 and recent corporate highlights.

Recent Corporate Highlights

  • Net-Zero 1 (“NZ1”): Gevo has received a conditional commitment for a loan guarantee with borrowing capacity of $1.6 billion (including capitalized interest during construction) from the U.S. Department of Energy (“DOE”) Loan Programs Office (“LPO”) for the NZ1 project in South Dakota. We believe this significant milestone signals the strength of the project to finance the world’s first large-scale, net-zero-emissions alcohol-to-jet production facility.
  • Red Trail Asset Acquisition: Gevo has entered into a definitive agreement to acquire the ethanol production and carbon capture and sequestration (“CCS”) assets of Red Trail Energy, LLC (“Red Trail Energy”). The Adjusted EBITDA1 from the Red Trail Energy assets, when combined with Adjusted EBITDA1 from Gevo’s renewable natural gas (“RNG”), Verity and other businesses, is expected to make Gevo’s Adjusted EBITDA1 positive in 2025.
  • CultivateAI Acquisition: Gevo acquired Cultivate Agricultural Intelligence, LLC (“CultivateAI”), which leverages drone and satellite-based imaging and GIS mapping to generate digital inventories for agriculture and land use, for its Verity business unit. We believe the integration of CultivateAI into the Verity platform will provide comprehensive, highest quality, data-driven solutions for carbon abatement in food, feed, fuels, and industrial markets, while simultaneously helping farmers improve their operations, sustainability, and profitability.
  • Ethanol to Olefins (“ETO”) Patent: The U.S. Patent and Trademark Office has granted to Gevo two patents for its ETO process. This process is designed to improve the cost and yields of drop-in, bio-based hydrocarbon fuels and chemicals from ethanol, and adds to Gevo’s global portfolio of more than 300 patents, as well as proprietary processes and know-how concerning processes to convert carbohydrates to hydrocarbons.
  • Sale of Investment Tax Credits: Gevo announced the sale of Investment Tax Credits, monetizing Inflation Reduction Act (“IRA”) credits generated from the commercialization of its renewable natural gas (“RNG”) facility.

______________________
1 Adjusted EBITDA is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization, inclusive of the value of monetizable tax credits such as 45-Q and 45-Z and excluding project development costs.

2024 Third Quarter Financial Highlights

  • Ended the third quarter with cash, cash equivalents and restricted cash of $292.9 million.
  • Combined revenue and interest and investment income was $5.8 million for the third quarter of 2024. For the nine months ended September 30, 2024, combined revenue and interest and investment income was $23.8 million.
  • On a standalone basis, our RNG subsidiary generated revenue of $2.0 million in the third quarter of 2024, consisting of RNG sales of 101,101 MMBtu for $0.2 million and $1.8 million of net proceeds from sales of environmental attributes. This revenue decreased relative to the same period in 2023, primarily due to lower sales of environmental attributes as a result of a buildup of environmental attribute inventory. The buildup of inventory is in anticipation of receiving the final pathway approval under the LCFS Program, which we expect to result in a lower carbon intensity (“CI”) score and result in a potentially higher value when the inventory is released and sold. This CI pathway approval is anticipated during the first quarter of 2025.
  • Loss from operations of $24.0 million for the third quarter.
  • Non-GAAP adjusted EBITDA loss2 of $16.7 million for the third quarter.
  • Investment Tax Credit sale proceeds of $15.3 million are reflected in the Statement of Cash Flows, Investing Activities, as a capital-related items, net of adjustments.
  • On a standalone basis, our RNG subsidiary generated standalone GAAP loss from operations of $2.8 million, and non-GAAP adjusted EBITDA loss2 of $1.2 million for the third quarter.
  • Net loss per share of $0.09 for the third quarter.

____________________
2 Adjusted EBITDA is a non-GAAP measure calculated by adding back depreciation and amortization, allocated intercompany expenses for shared service functions, and non-cash stock-based compensation to GAAP loss from operations. A reconciliation of adjusted EBITDA to GAAP loss from operations is provided in the financial statement tables following this release. Adjusted EBITDA was referred to as “cash EBITDA” in previous periods.

Management Comment

Lynn Smull, Gevo’s Chief Financial Officer, commented, “Securing the DOE's $1.6 billion loan guarantee conditional commitment is a transformative milestone for Gevo and our Net-Zero 1 project. Reaching the DOE commitment illustrates Gevo’s pioneering ability to develop and reduce the risk of a financially attractive, large-scale, net-zero SAF production facility. Additionally, given the acquisition of the Red Trail Energy assets combined with Verity and expected near term RNG growth, we believe that we are well-positioned to achieve positive Adjusted EBITDA in 2025. The investments we’re making are strategically positioning us for long-term growth in new industries that need low-carbon products, while managing our cash and capital expenditures to execute from a position of financial strength.”

Dr. Patrick Gruber, Gevo’s Chief Executive Officer, added, “Everything we do is tied together by the concept of carbon abatement as a means to create value in the clean energy market sector, profit for the company, and value for our shareholders. The progress on Net-Zero business systems, which include NZ1 and the Red Trail Energy asset acquisition, underscores our commitment to developing our businesses to abate carbon and serving enormous, growing markets. Our advancements in areas like Verity, with our CultivateAI acquisition, reflect our commitment to creating resilient value chains that support carbon abatement from field to flight, in the case of SAF, but also for other fuels, chemicals and food chains. In the Net-Zero business system, it is all about making products that people value, and doing it profitably, just like any other business. There is more, though. It’s also about rural economic development, energy security, creation of jobs, and rewarding farmers. Overall, it’s all about carbon abatement across the whole of the supply chain, while everyone in the supply chain benefits economically.”

2024 Third Quarter Financial Results

Operating revenue. During the three months ended September 30, 2024, operating revenue decreased $2.6 million compared to the three months ended September 30, 2023, primarily due to lower sales of environmental attributes from our RNG project. This is due to a buildup of environmental attribute inventory in anticipation of receiving the final pathway approval under the LCFS Program, which we expect to result in a lower CI score. Said approval is anticipated during the first quarter of 2025. During the three months ended September 30, 2024, we sold 101,101 MMBtu of RNG from our RNG project, resulting in RNG sales of $0.2 million and environmental attribute sales of $1.8 million.

Cost of production. Cost of production remained flat during the three months ended September 30, 2024, compared to the three months ended September 30, 2023.

Depreciation and amortization. Depreciation and amortization decreased $1.5 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, due to the timing of sales of environmental attribute inventory, which includes allocated depreciation and amortization.

Research and development expense. Research and development expenses decreased $0.4 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to decreased consulting expenses and professional fees.

General and administrative expense. General and administrative expense increased $1.2 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to increases in personnel costs related to the hiring of highly qualified and skilled professionals, and professional consulting fees, partially offset by a decrease in stock-based compensation. On an annual basis, we assess our corporate cost allocation estimates across all segments to reflect the use of centralized administrative functions as well as the allocation of personnel costs related to our project development efforts.

Project development costs. Project development costs are primarily related to our Net-Zero Projects and Verity, which consist primarily of employee expenses, preliminary engineering costs, and technical consulting costs. Project development costs increased $1.8 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to increases in personnel costs, consulting fees, and costs related to our USDA Grant, which have not yet been reimbursed.

Facility idling costs. Facility idling costs are related to the care and maintenance of our Luverne Facility. Facility idling costs decreased $0.4 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023.

Loss from operations. The Company’s loss from operations increased $3.3 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to the increase in costs for our Net-Zero and Verity projects.

Interest expense. Interest expense increased $0.6 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, and was primarily comprised of interest on the Remarketed Bonds.

Interest and investment income. Interest and investment income decreased $1.4 million during the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to the usage of cash for our capital projects and operating costs, resulting in a lower balance of cash equivalent investments during the three months ended September 30, 2024.

Other income (expense), net. Other income (expense), net remained flat for the three months ended September 30, 2024, compared to the three months ended September 30, 2023.

Webcast and Conference Call Information

Hosting today’s conference call at 4:30 p.m. ET will be Dr. Patrick R. Gruber, Chief Executive Officer, L. Lynn Smull, Chief Financial Officer, and Dr. Eric Frey, Vice President of Finance. They will review Gevo’s financial results and provide an update on recent corporate highlights.

To participate in the live call, please register through the following event weblink: https://register.vevent.com/register/BId0c13b561f9d442ba7211ad0cbc56dbc. After registering, participants will be provided with a dial-in number and pin.

To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/ggx3po5y.

A webcast replay will be available two hours after the conference call ends on November 7, 2024. The archived webcast will be available in the Investor Relations section of Gevo’s website at www.gevo.com.

About Gevo

Gevo's mission is to convert renewable energy and biogenic carbon into sustainable fuels and chemicals with a net-zero or better carbon footprint. Gevo’s innovative technology can be used to make a variety of products, including SAF, motor fuels, chemicals, and other materials. Gevo’s business model includes developing, financing, and operating production facilities for these renewable fuels and other products. It currently runs one of the largest dairy-based RNG facilities in the United States. It also owns the world’s first production facility for specialty alcohol-to-jet (“ATJ”) fuels and chemicals. Gevo emphasizes the importance of sustainability by tracking and verifying the carbon footprint of its business systems through its Verity subsidiary.

Learn more at Gevo’s website: www.gevo.com.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, the financing and the timing of our NZ1 project, the agreement with LG Chem, the DOE loan guarantee process, the Red Trail Energy acquisition and timing of its closing, the successful integration of the CultivateAI acquisition, the success and revenue of Verity, the success of our ETO business, our financial condition, our results of operation and liquidity, our business plans, our business development activities, our Net-Zero Projects, financial projections related to our business, our RNG project, our fuel sales agreements, our plans to develop our business, our ability to successfully develop, construct and finance our operations and growth projects, our ability to achieve cash flow from our planned projects, the ability of our products to contribute to lower greenhouse gas emissions, particulate and sulfur pollution, and other statements that are not purely statements of historical fact. These forward-looking statements are made based on the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in our most recent Annual Report on Form 10-K and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Non-GAAP Financial Information

This press release contains a financial measure that does not comply with U.S. generally accepted accounting principles (“GAAP”), including non-GAAP adjusted EBITDA. Non-GAAP adjusted EBITDA excludes depreciation and amortization, allocated intercompany expenses for shared service functions, and non-cash stock-based compensation from GAAP loss from operations. Management believes this measure is useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. This non-GAAP financial measure also facilitates management’s internal comparisons to Gevo’s historical performance as well as comparisons to the operating results of other companies. In addition, Gevo believes this non-GAAP financial measure is useful to investors because it allows for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Gevo’s operating performance. A reconciliation between GAAP and non-GAAP financial information is provided below.

      
Gevo, Inc.
Condensed Consolidated Balance Sheets
(Unaudited, in thousands, except share and per share amounts)
      
 September 30,
2024
    December 31,
2023
Assets     
Current assets     
Cash and cash equivalents$223,227  $298,349 
Restricted cash 1,489   77,248 
Trade accounts receivable, net 1,411   2,623 
Inventories 5,846   3,809 
Prepaid expenses and other current assets 4,659   4,353 
Total current assets 236,632   386,382 
Property, plant and equipment, net 219,804   211,563 
Restricted cash 68,155    
Operating right-of-use assets 1,149   1,324 
Finance right-of-use assets 2,236   210 
Intangible assets, net 8,548   6,524 
Goodwill 3,742    
Deposits and other assets 63,524   44,319 
Total assets$603,790  $650,322 
Liabilities     
Current liabilities     
Accounts payable and accrued liabilities$26,396  $22,752 
Operating lease liabilities 351   532 
Finance lease liabilities 1,873   45 
Loans payable 53   130 
2021 Bonds payable, net    67,967 
Total current liabilities 28,673   91,426 
Remarketed Bonds payable, net 66,902    
Loans payable    21 
Operating lease liabilities 1,051   1,299 
Finance lease liabilities 613   187 
Other long-term liabilities 1,830    
Total liabilities 99,069   92,933 
Stockholders' Equity     
Common stock, $0.01 par value per share; 500,000,000 shares authorized; 239,407,448 and 240,499,833 shares issued and outstanding at September 30, 2024, and December 31, 2023, respectively. 2,394   2,405 
Additional paid-in capital 1,284,957   1,276,581 
Accumulated deficit (782,630)  (721,597)
Total stockholders' equity 504,721   557,389 
Total liabilities and stockholders' equity$603,790  $650,322 
        
        


            
Gevo, Inc.
Condensed Consolidated Statements of Operations
(Unaudited, in thousands, except share and per share amounts)
            
 Three Months Ended
September 30, 
    Nine Months Ended
September 30, 
 2024  2023  2024  2023 
Total operating revenues$1,965  $4,528  $11,215  $12,826 
Operating expenses:           
Cost of production 2,544   2,480   8,554   8,836 
Depreciation and amortization 3,494   4,994   12,222   14,323 
Research and development expense 1,113   1,558   4,302   4,716 
General and administrative expense 11,679   10,522   35,342   31,891 
Project development costs 6,593   4,789   19,648   10,635 
Facility idling costs 550   911   2,325   2,923 
Total operating expenses 25,973   25,254   82,393   73,324 
Loss from operations (24,008)  (20,726)  (71,178)  (60,498)
Other income (expense)           
Interest expense (1,107)  (540)  (2,762)  (1,615)
Interest and investment income 3,843   5,261   12,579   14,083 
Other income, net 116   305   328   292 
Total other income, net 2,852   5,026   10,145   12,760 
Net loss$(21,156) $(15,700) $(61,033) $(47,738)
Net loss per share - basic and diluted$(0.09) $(0.07) $(0.25) $(0.20)
Weighted-average number of common shares outstanding - basic and diluted 239,445,900   239,537,811   239,767,047   238,100,986 
                
                


            
Gevo, Inc.
Condensed Consolidated Statements of Comprehensive Loss
(Unaudited, in thousands)
            
 Three Months Ended
September 30, 
 Nine Months Ended
September 30, 
 2024  2023  2024  2023 
Net loss$(21,156) $(15,700) $(61,033) $(47,738)
Other comprehensive income (loss):           
Unrealized gain (loss) on available-for-sale securities          1,040 
Comprehensive loss$(21,156) $(15,700) $(61,033) $(46,698)
                
                


                 
Gevo, Inc.
Condensed Consolidated Statements of Stockholders Equity
(Unaudited, in thousands, except share amounts)
                 
 For the Nine Months Ended September 30, 2024 and 2023
 Common Stock    Accumulated Other  Accumulated  Stockholders’
 Shares    Amount    Paid-In Capital    Comprehensive Loss    Deficit    Equity
Balance, December 31, 2023240,499,833  $2,405  $1,276,581  $  $(721,597) $557,389 
Non-cash stock-based compensation      12,485         12,485 
Stock-based awards and related share issuances, net6,015,823   60   481         541 
Repurchase of common stock(7,190,006)  (72)  (4,638)        (4,710)
Issuance of common stock upon exercise of warrants81,798   1   48         49 
Net loss            (61,033)  (61,033)
Balance, September 30, 2024239,407,448  $2,394  $1,284,957  $  $(782,630) $504,721 
                 
Balance, December 31, 2022237,166,625  $2,372  $1,259,527  $(1,040) $(655,382) $605,477 
Non-cash stock-based compensation      12,752         12,752 
Stock-based awards and related share issuances, net3,086,082   31   (31)         
Other comprehensive income         1,040      1,040 
Net loss            (47,738)  (47,738)
Balance, September 30, 2023240,252,707  $2,403  $1,272,248  $  $(703,120) $571,531 
                       
                       


      
Gevo, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited, in thousands)
      
 Nine Months Ended
September 30, 
 2024  2023 
Operating Activities     
Net loss$(61,033) $(47,738)
Adjustments to reconcile net loss to net cash used in operating activities:     
Stock-based compensation 12,485   12,752 
Depreciation and amortization 12,222   14,323 
Amortization of marketable securities discount    (102)
Other noncash expense 1,847   655 
Changes in operating assets and liabilities, net of effects of acquisition:     
Accounts receivable 1,417   (1,766)
Inventories (1,542)  1,137 
Prepaid expenses and other current assets, deposits and other assets (10,750)  (816)
Accounts payable, accrued expenses and non-current liabilities 6,814   427 
Net cash used in operating activities (38,540)  (21,128)
Investing Activities     
Acquisitions of property, plant and equipment (36,459)  (61,413)
Proceeds from sale of investment tax credit 15,336    
Payment of earnest money deposit (10,000)   
Acquisition of CultivateAI, net (6,070)   
Proceeds from maturity of marketable securities    168,550 
Proceeds from sale of property, plant and equipment    34 
Net cash (used in) provided by investing activities (37,193)  107,171 
Financing Activities     
Proceeds from issuance of Remarketed Bonds, net 68,155    
Extinguishment of 2021 Bonds, net (68,155)   
Payment of debt offering costs (1,665)   
Proceeds from the exercise of warrants 49    
Payment of loans payable (89)  (128)
Payment of finance lease liabilities (578)  (22)
Repurchases of common stock (4,710)   
Net cash used in financing activities (6,993)  (150)
Net (decrease) increase in cash and cash equivalents (82,726)  85,893 
Cash, cash equivalents and restricted cash at beginning of period 375,597   315,376 
Cash, cash equivalents and restricted cash at end of period$292,871  $401,269 
        
        


            
Gevo, Inc.
Reconciliation of GAAP to Non-GAAP Financial Information
(Unaudited, in thousands)
            
 Three Months Ended
September 30, 
 Nine Months Ended
September 30, 
 2024     2023     2024     2023 
Non-GAAP Adjusted EBITDA (Consolidated):           
Loss from operations$(24,008) $(20,726) $(71,178) $(60,498)
Depreciation and amortization 3,494   4,994   12,222   14,323 
Stock-based compensation 3,786   4,132   12,485   12,752 
Non-GAAP adjusted EBITDA (loss) (Consolidated)$(16,728) $(11,600) $(46,471) $(33,423)
                
                


 Three Months Ended
September 30, 
 Nine Months Ended
September 30, 
 2024  2023  2024  2023 
Non-GAAP Adjusted EBITDA (Gevo NW Iowa RNG):           
Loss from operations$(2,832) $(1,120) $(5,263) $(6,382)
Depreciation and amortization 672   1,914   3,347   5,099 
Allocated intercompany expenses for shared service functions 890   890   2,671   2,671 
Stock-based compensation 48   18   125   59 
Non-GAAP adjusted EBITDA (loss) (Gevo NW Iowa RNG)$(1,222) $1,702  $880  $1,447 
                

Media Contact
Heather Manuel
VP of Stakeholder Engagement & Partnerships
PR@gevo.com

Investor Contact
Eric Frey, PhD
Vice President of Finance & Strategy
IR@Gevo.com


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.